People · Operator

SEAN IANCHULEV

Named in public records as an officer, director or promoter · active 2010–2013 · Other Health Care, Pharmaceuticals

2
Companies
8
Filings
$17.9M
Combined raised · real
Serial
Operator type
Companies
CompanyRoleSectorStageRaised · realValue · estTied
Corinthian Ophthalmic, Inc.Other Health CareSeed$12.9M$40.6M2010
Kurobe Pharmaceuticals, Inc.PharmaceuticalsSeries A$5.0M$154.9M2013
Operator network

SEAN IANCHULEV at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.

Ernest Mario · 9 companies · 1 sharedErnest MarioFRED ESHELMAN · 5 companies · 1 sharedFRED ESHELMANJOHN MACK · 3 companies · 1 sharedJOHN MACKJOHN HAND · 2 companies · 1 sharedJOHN HANDBERNARD BALLOU · 1 companies · 1 sharedBERNARD BALLOUMARK PACKER · 1 companies · 1 sharedMARK PACKERSkip Ballou · 1 companies · 1 sharedSkip BallouCurt LaBelle · 7 companies · 1 sharedCurt LaBelleBARRY BUTLER · 6 companies · 1 sharedBARRY BUTLEREiji Katayama · 1 companies · 1 sharedEiji KatayamaHaley Butler · 1 companies · 1 sharedHaley ButlerNaohito Takahashi · 1 companies · 1 sharedNaohito TakahashiYvonne Gallimore · 1 companies · 1 sharedYvonne GallimoreCorinthian Ophthalmic, Inc. · $12.9M raisedCorinthian Ophthalmic…Kurobe Pharmaceuticals, Inc. · $5.0M raisedKurobe Pharmaceutical…SEAN IANCHULEVSI
SEAN IANCHULEV Company Co-operator (ring = serial)Hover to isolate ties · click to open
Co-operators (shared boards)

People named alongside SEAN IANCHULEV on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.

OperatorSharedTheir companies
Ernest Mario19
Curt LaBelle17
BARRY BUTLER16
FRED ESHELMAN15
JOHN MACK13
JOHN HAND12
Haley Butler11
Naohito Takahashi11
BERNARD BALLOU11
MARK PACKER11
Skip Ballou11
Eiji Katayama11
Yvonne Gallimore11

People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.